In randomised control trial in MASLD patients without diabetes, LiverMultiScan monitored improvements in liver fat and liver disease activity following 12-week liraglutide treatment. Low-calorie diet achieved equivalent improvements.
Welcome to Perspectum Medical Education
You are entering a website that is scientific in nature and created for healthcare professionals.
Are you a healthcare professional?